Source: Virtual Congress 2021 – COVID-19 and management of lung cancer



Rating:

Share or cite this content

Citations should be made in the following way:
M. Chrysanthidis (Athens, Greece), A. Charpidou (Athens, Greece), E. Dimakakos (Athens, Greece), D. Grapsa (Athens, Greece), P. Bakakos (Athens, Greece), G. Stratakos (Athens, Greece), K. Syrigos (Athens, Greece). Evaluation of cancer-associated thrombosis risk in patients with lung adenocarcinoma using the COMPASS-CAT risk assessment model. 3854

Member's Comments

No comment yet.

Related content which might interest you: Venous thromboembolic disease in patients with small cell lung cancer: incidence and clinicopathological risk factors Source: Virtual Congress 2020 – Pulmonary embolism and beyond Year: 2020 Prevalence of and risk factors for pulmonary complications after lung cancer surgery in elderly patients with preserved lung function Source: International Congress 2018 – Lung cancer: modern therapies and beyond Year: 2018 Cumulative incidence and associated risk factor of chronic pulmonary infection after lung resection surgery for lung cancer Source: International Congress 2019 – Diagnosis of lung cancer Year: 2019 Non-invasive biomarkers for the evaluation of a patient at risk for lung cancer Source: Annual Congress 2013 –Early detection of lung cancer Year: 2013 Comparison of risk prediction scores for venous thromboembolism in lung cancer patients: a retrospective cohort study Source: International Congress 2019 – Symptoms, risks, complications and palliative care in thoracic oncology Year: 2019 Interstital lung disease rates and risk factors in a UK lung cancer screening trial Source: International Congress 2018 – The world of idiopathic pulmonary fibrosis (IPF): global registries Year: 2018 Does d-dimer level predict pulmonary thromboembolism diagnosis in patients with lung cancer? Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD Year: 2019 Preoperative biopsy risk for recurrence?: A retrospective study of risk factors for recurrence of stage 1A non-small cell lung cancer Source: International Congress 2017 – How to reach peripheral lesions: (radial EBUS, CLE, navigation, etc.) and treat airleaks Year: 2017 Prior lung disease and risk of lung cancer in women Source: Eur Respir J 2005; 26: Suppl. 49, 598s Year: 2005 Evaluation of cardiovascular risk in a lung cancer screening cohort: what value does it bring? Source: Breathe, 16 (4) 200204; 10.1183/20734735.0204-2020 Year: 2020 Incidence, predictors and prognostic significance of thromboembolic disease in patients with advanced ALK-rearranged non-small cell lung cancer Source: Eur Respir J, 51 (5) 1702431; 10.1183/13993003.02431-2017 Year: 2018 Risk factors predicting mortality in patients with lung abscess Source: Annual Congress 2012 - Respiratory infections: prognosis and outcome Year: 2012 Incidence and predictive factors of lung cancer in patients with idiopathic pulmonary fibrosis Source: ERJ Open Res, 4 (1) 00111-2016; 10.1183/23120541.00111-2016 Year: 2018 Characteristics, incidence, risk factors, and practical management of pneumonitis associated with anti-PD-1 immunotherapy in patients with non-small cell lung cancer Source: International Congress 2019 – Treatment of lung cancer Year: 2019 Validation of a gene-based lung cancer risk test (Respiragene) for high risk smokers: A targeted approach to early detection of lung cancer Source: Annual Congress 2010 - Lung cancer, idiopathic pulmonary fibrosis and sarcoidosis: the genetic approach Year: 2010 Comparision of two preoperative risk assessment algorithms in lung cancer surgery. Source: International Congress 2017 – Evaluating lung function, dyspnoea and related respiratory diseases Year: 2017 Risk quantification for postoperative pulmonary complications after pulmonary resection in lung cancer patients Source: Annual Congress 2008 - Risk assessment and treatment of complications in thoracic surgery patients Year: 2008 Candidacolonization in lung cancer patients and its role as a prognostic factor for infection occurrence during hospitalization Source: Eur Respir J 2003; 22: Suppl. 45, 433s Year: 2003 Risk factors for early mortality in lung cancer Source: Annual Congress 2012 - Epidemiology and care research of lung cancer Year: 2012 Risk assessment in scleroderma patients with newly diagnosed pulmonary arterial hypertension: application of the ESC/ERS risk prediction model Source: Eur Respir J, 52 (4) 1800497; 10.1183/13993003.00497-2018 Year: 2018